JACOB HOFFMAN: Open Payments
NPI 1114704483 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 35 payments from 15 companies in 2025. Trend: 2023 $43 · 2024 $783 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $181 |
| Lilly USA, LLC | 8 | $164 |
| Amgen Inc. | 1 | $103 |
| PFIZER INC. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| ABBVIE INC. | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $35 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
Products named: Ozempic, MOUNJARO, TAVNEOS, PREVNAR 20, JARDIANCE, VRAYLAR, AIRSUPRA, INJECTAFER.
Industry payments across TX — which companies pay providers there.
